Compositions and methods for treating pulmonary hypertension
US-2025249071-A1 · Aug 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Knopf John patents
Knopf John is listed as an inventor on 102 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Knopf John |
| Total patents | 102 |
| First publication | Jan 8, 2015 |
| Latest publication | Aug 7, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for treating pulmonary hypertension
US-2025241988-A1 · Jul 31, 2025 · US
ALK7 binding proteins and uses thereof
US-12365736-B2 · Jul 22, 2025 · US
Compositions and methods for treating pulmonary hypertension
US-12343378-B2 · Jul 1, 2025 · US
ALK1 receptor and ligand antagonists and uses thereof
US-12144860-B2 · Nov 19, 2024 · US
Method for promoting bone growth using activin-actriia antagonists
US-2024358793-A1 · Oct 31, 2024 · US
Alk7 antagonists and uses thereof
US-2024309098-A1 · Sep 19, 2024 · US
ALK7 antagonists and uses thereof
US-12024563-B2 · Jul 2, 2024 · US
ALK7 Binding Proteins and Uses Thereof
US-2023416379-A1 · Dec 28, 2023 · US
ALK7:ActRIIB heteromultimers and uses thereof
US-11827689-B2 · Nov 28, 2023 · US
Recent patents
Latest publications not already listed above.
Methods and compositions for increasing red blood cells
US-11807673-B2 · Nov 7, 2023 · US
Compositions and methods for treating pulmonary hypertension
US-2023233648-A1 · Jul 27, 2023 · US
ALK7 binding proteins and uses thereof
US-11708414-B2 · Jul 25, 2023 · US
Compositions and methods for treating pulmonary hypertension
US-11622992-B2 · Apr 11, 2023 · US
Compositions and methods for treating pulmonary hypertension
US-11497794-B2 · Nov 15, 2022 · US
Alk7 binding proteins and uses thereof
US-2022348685-A1 · Nov 3, 2022 · US
Alk1 receptor and ligand antagonists and uses thereof
US-2022296708-A1 · Sep 22, 2022 · US
Alk7 antagonists and uses thereof
US-2022289852-A1 · Sep 15, 2022 · US
Variants derived from actriib and uses therefor
US-2022281951-A1 · Sep 8, 2022 · US
Method for promoting bone growth using activin-actriia antagonists
US-2022211806-A1 · Jul 7, 2022 · US
Compositions and methods for treating pulmonary hypertension
US-11318188-B2 · May 3, 2022 · US
Alk7:actriib heteromultimers and uses thereof
US-2022119491-A1 · Apr 21, 2022 · US
Methods and compositions for modulating angiogenesis and pericyte composition
US-2022017600-A1 · Jan 20, 2022 · US
Methods for increasing thermogenic adipocytes
US-2022017639-A1 · Jan 20, 2022 · US
Compositions and methods for treating pulmonary hypertension
US-11219666-B2 · Jan 11, 2022 · US
Methods and compositions for modulating angiogenesis and pericyte composition
US-2021388104-A1 · Dec 16, 2021 · US
Alk7 binding proteins and uses thereof
US-2021324089-A1 · Oct 21, 2021 · US
Compositions and methods for treating pulmonary hypertension
US-2021299220-A1 · Sep 30, 2021 · US
Compositions and methods for treating pulmonary hypertension
US-2021299216-A1 · Sep 30, 2021 · US
Method for promoting bone growth using activin-actriia antagonists
US-11129873-B2 · Sep 28, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Acceleron Pharma Inc | 107 |
| Knopf John | 4 |
| Seehra Jasbir | 4 |
| Adimab Llc | 4 |
| Ludwig Inst For Cancer Res Ltd | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2319/30 | 81 |
| C07K14/71 | 80 |
| A61P35/00 | 55 |
| A61K38/179 | 53 |
| A61K45/06 | 45 |